Cargando…
Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study
PURPOSE: Neoadjuvant radiotherapy (NeoRT) improves tumor local control and facilitates tumor resection in many cancers. Some clinical studies demonstrated that both timing of surgery and RT schedule influence tumor dissemination, and subsequently patient overall survival. Previously, we developed a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724034/ https://www.ncbi.nlm.nih.gov/pubmed/34993143 http://dx.doi.org/10.3389/fonc.2021.784437 |
_version_ | 1784625838458667008 |
---|---|
author | Lallemand, François Leroi, Natacha Blacher, Silvia Bahri, Mohamed Ali Balteau, Evelyne Coucke, Philippe Noël, Agnès Plenevaux, Alain Martinive, Philippe |
author_facet | Lallemand, François Leroi, Natacha Blacher, Silvia Bahri, Mohamed Ali Balteau, Evelyne Coucke, Philippe Noël, Agnès Plenevaux, Alain Martinive, Philippe |
author_sort | Lallemand, François |
collection | PubMed |
description | PURPOSE: Neoadjuvant radiotherapy (NeoRT) improves tumor local control and facilitates tumor resection in many cancers. Some clinical studies demonstrated that both timing of surgery and RT schedule influence tumor dissemination, and subsequently patient overall survival. Previously, we developed a pre-clinical model demonstrating the impact of NeoRT schedule and timing of surgery on metastatic spreading. We report on the impact of NeoRT on tumor microenvironment by MRI. METHODS: According to our NeoRT model, MDA-MB 231 cells were implanted in the flank of SCID mice. Tumors were locally irradiated (PXI X-Rad SmART) with 2x5Gy and then surgically removed at different time points after RT. Diffusion-weighted (DW) and Dynamic contrast enhancement (DCE) MRI images were acquired before RT and every 2 days between RT and surgery. IntraVoxel Incoherent Motion (IVIM) analysis was used to obtain information on intravascular diffusion, related to perfusion (F: perfusion factor) and subsequently tumor vessels perfusion. For DCE-MRI, we performed semi-quantitative analyses. RESULTS: With this experimental model, a significant and transient increase of the perfusion factor F [50% of the basal value (n=16, p<0.005)] was observed on day 6 after irradiation as well as a significant increase of the WashinSlope with DCE-MRI at day 6 (n=13, p<0.05). Using immunohistochemistry, a significant increase of perfused vessels was highlighted, corresponding to the increase of perfusion in MRI at this same time point. Moreover, Tumor surgical resection during this peak of vascularization results in an increase of metastasis burden (n=10, p<0.05). CONCLUSION: Significant differences in perfusion-related parameters (F and WashinSlope) were observed on day 6 in a neoadjuvant radiotherapy model using SCID mice. These modifications are correlated with an increase of perfused vessels in histological analysis and also with an increase of metastasis spreading after the surgical procedure. This experimental observation could potentially result in a way to personalize treatment, by modulating the time of surgery guided on MRI functional data, especially tumor perfusion. |
format | Online Article Text |
id | pubmed-8724034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87240342022-01-05 Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study Lallemand, François Leroi, Natacha Blacher, Silvia Bahri, Mohamed Ali Balteau, Evelyne Coucke, Philippe Noël, Agnès Plenevaux, Alain Martinive, Philippe Front Oncol Oncology PURPOSE: Neoadjuvant radiotherapy (NeoRT) improves tumor local control and facilitates tumor resection in many cancers. Some clinical studies demonstrated that both timing of surgery and RT schedule influence tumor dissemination, and subsequently patient overall survival. Previously, we developed a pre-clinical model demonstrating the impact of NeoRT schedule and timing of surgery on metastatic spreading. We report on the impact of NeoRT on tumor microenvironment by MRI. METHODS: According to our NeoRT model, MDA-MB 231 cells were implanted in the flank of SCID mice. Tumors were locally irradiated (PXI X-Rad SmART) with 2x5Gy and then surgically removed at different time points after RT. Diffusion-weighted (DW) and Dynamic contrast enhancement (DCE) MRI images were acquired before RT and every 2 days between RT and surgery. IntraVoxel Incoherent Motion (IVIM) analysis was used to obtain information on intravascular diffusion, related to perfusion (F: perfusion factor) and subsequently tumor vessels perfusion. For DCE-MRI, we performed semi-quantitative analyses. RESULTS: With this experimental model, a significant and transient increase of the perfusion factor F [50% of the basal value (n=16, p<0.005)] was observed on day 6 after irradiation as well as a significant increase of the WashinSlope with DCE-MRI at day 6 (n=13, p<0.05). Using immunohistochemistry, a significant increase of perfused vessels was highlighted, corresponding to the increase of perfusion in MRI at this same time point. Moreover, Tumor surgical resection during this peak of vascularization results in an increase of metastasis burden (n=10, p<0.05). CONCLUSION: Significant differences in perfusion-related parameters (F and WashinSlope) were observed on day 6 in a neoadjuvant radiotherapy model using SCID mice. These modifications are correlated with an increase of perfused vessels in histological analysis and also with an increase of metastasis spreading after the surgical procedure. This experimental observation could potentially result in a way to personalize treatment, by modulating the time of surgery guided on MRI functional data, especially tumor perfusion. Frontiers Media S.A. 2021-12-21 /pmc/articles/PMC8724034/ /pubmed/34993143 http://dx.doi.org/10.3389/fonc.2021.784437 Text en Copyright © 2021 Lallemand, Leroi, Blacher, Bahri, Balteau, Coucke, Noël, Plenevaux and Martinive https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Lallemand, François Leroi, Natacha Blacher, Silvia Bahri, Mohamed Ali Balteau, Evelyne Coucke, Philippe Noël, Agnès Plenevaux, Alain Martinive, Philippe Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study |
title | Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study |
title_full | Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study |
title_fullStr | Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study |
title_full_unstemmed | Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study |
title_short | Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study |
title_sort | tumor microenvironment modifications recorded with ivim perfusion analysis and dce-mri after neoadjuvant radiotherapy: a preclinical study |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724034/ https://www.ncbi.nlm.nih.gov/pubmed/34993143 http://dx.doi.org/10.3389/fonc.2021.784437 |
work_keys_str_mv | AT lallemandfrancois tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT leroinatacha tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT blachersilvia tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT bahrimohamedali tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT balteauevelyne tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT couckephilippe tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT noelagnes tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT plenevauxalain tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy AT martinivephilippe tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy |